Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience

de Castro, T; Jochheim, LS; Bathon, M; Welland, S; Scheiner, B; Shmanko, K; Roessler, D; Ben Khaled, N; Jeschke, M; Ludwig, JM; Marquardt, JU; Weinmann, A; Pinter, M; Lange, CM; Vogel, A; Saborowski, A

Vogel, A (通讯作者)，Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Carl Neuberg Str 1, D-30625 Hannover, Germany.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022; 14 ():

Abstract

Objective: Evaluation of the efficacy and safety of atezolizumab/bevacizumab in a real-world HCC cohort, including patients with impaired liver functi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索